-
Product Name
Interferon alpha antibody
- Documents
-
Description
Interferon alpha Mouse Monoclonal antibody. Positive WB detected in Recombinant protein. Observed molecular weight by Western-blot: 22 kDa
-
Tested applications
ELISA, WB
-
Species reactivity
Human; other species not tested.
-
Alternative names
IFL antibody; IFN antibody; IFN ALPHA antibody; IFN alpha 1/13 antibody; IFNA@ antibody; IFNA1 antibody; IFNA13 antibody; Interferon alpha 1/13 antibody; Interferon alpha D antibody; interferon antibody; alpha 1 antibody; Interferon-α1 antibody; LeIF D antibody
-
Isotype
Mouse IgG2a
-
Preparation
This antibody was obtained by immunization of Interferon alpha recombinant protein (Accession Number: NM_024013). Purification method: Protein A purified.
-
Clonality
Monoclonal
-
Formulation
PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
-
Storage instructions
Store at -20℃. DO NOT ALIQUOT
-
Applications
Recommended Dilution:
WB: 1:5000-1:50000
-
Validations
Recombinant protein were subjected to SDS PAGE followed by western blot with Catalog No:107353(IFNA1 Antibody) at dilution of 1:40000
-
Background
IFNA1 (interferon-alpha) is a member of the Type I IFN (1) family best known for their antiviral activity. It is a key cytokine regulating the activity of B cells, T-helper cells (Th cells), cDCs and natural killer cells (NK cells). Interferon-alpha induces B cell maturation into plasma cells and immunoglobulin production. Interferon-alpha plays an important role in the pathogenesis of systemic lupus erythematosus (SLE). Interferon-alpha was the first cytokine to show clinical benefit in the treatment of certain types of cancer, including melanoma, chronic myelogenous leukemia, and renal cancer.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"